ABK Biomedical Revenue and Competitors
Estimated Revenue & Valuation
- ABK Biomedical's estimated annual revenue is currently $5.1M per year.
- ABK Biomedical's estimated revenue per employee is $125,500
- ABK Biomedical's total funding is $79M.
Employee Data
- ABK Biomedical has 41 Employees.
- ABK Biomedical grew their employee count by 3% last year.
ABK Biomedical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | VP Clinical Development & Regulatory Affairs | Reveal Email/Phone |
3 | VP R&D and Nuclear Operations | Reveal Email/Phone |
4 | Director, Product and Program Management | Reveal Email/Phone |
5 | Director Engineering | Reveal Email/Phone |
6 | Regulatory Affairs Director | Reveal Email/Phone |
7 | Co-Founder and Director for Biomaterials R&D | Reveal Email/Phone |
8 | Chief Business Officer | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Senior Manager, Quality Assurance | Reveal Email/Phone |
ABK Biomedical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is ABK Biomedical?
Combining a compelling clinical market with innovative biomaterials invented by Drs Bob Abraham, Daniel Boyd and Sharon Kehoe, The Three Founders saw the opportunity to transform an interventional radiology procedure called embolization
keywords:N/A
$79M
Total Funding
41
Number of Employees
$5.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ABK Biomedical News
Merit Medical, Sirtex Medical, ABK Biomedical, Young Pharmaceuticals. Global Tris Acryl Gelatin Microspheres Market Segmentation: Market...
ABK Biomedical, Inc., a Halifax, Nova Scotia, Canada-based medical device company dedicated to the research, development and commercialization of innovative embolic therapies, raised $30m in Series B funding. The round was co-led by F-Prime Capital and Varian Medical Systems. The company will ...
Other Companies in Halifax
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.6M | 42 | -5% | N/A |
#2 | N/A | 44 | 76% | N/A |
#3 | N/A | 45 | -8% | N/A |
#4 | $5.5M | 47 | 12% | N/A |
#5 | $3.5M | 48 | 12% | N/A |